Appili Therapeutics, Inc. (APLIF)
0.0055
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Appili Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2021 | 10.94 |
| September 28, 2021 | 10.88 |
| September 27, 2021 | 10.33 |
| September 24, 2021 | 9.950 |
| September 23, 2021 | 10.22 |
| September 22, 2021 | 9.773 |
| September 21, 2021 | 9.652 |
| September 20, 2021 | 9.324 |
| September 17, 2021 | 9.680 |
| September 16, 2021 | 9.955 |
| September 15, 2021 | 10.02 |
| September 14, 2021 | 10.09 |
| September 13, 2021 | 10.38 |
| September 10, 2021 | 9.740 |
| September 09, 2021 | 9.534 |
| September 08, 2021 | 9.857 |
| September 07, 2021 | 9.291 |
| September 03, 2021 | 9.129 |
| September 02, 2021 | 8.580 |
| September 01, 2021 | 8.497 |
| August 31, 2021 | 8.269 |
| August 30, 2021 | 8.094 |
| August 27, 2021 | 8.058 |
| August 26, 2021 | 9.008 |
| August 25, 2021 | 9.008 |
| Date | Value |
|---|---|
| August 24, 2021 | 8.541 |
| August 23, 2021 | 8.415 |
| August 20, 2021 | 8.280 |
| August 19, 2021 | 7.323 |
| August 18, 2021 | 7.168 |
| August 17, 2021 | 7.433 |
| August 16, 2021 | 7.706 |
| August 13, 2021 | 7.433 |
| August 12, 2021 | 7.433 |
| August 11, 2021 | 7.885 |
| August 10, 2021 | 7.566 |
| August 09, 2021 | 7.479 |
| August 06, 2021 | 7.810 |
| August 05, 2021 | 8.324 |
| August 04, 2021 | 8.673 |
| August 03, 2021 | 8.560 |
| August 02, 2021 | 9.358 |
| July 30, 2021 | 8.661 |
| July 29, 2021 | 8.038 |
| July 28, 2021 | 8.012 |
| July 27, 2021 | 7.522 |
| July 26, 2021 | 7.758 |
| July 23, 2021 | 7.752 |
| July 22, 2021 | 7.830 |
| July 21, 2021 | 6.824 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| InMed Pharmaceuticals, Inc. | 6.755 |
| NervGen Pharma Corp. | 13.46 |
| Milestone Pharmaceuticals, Inc. | 4.784 |
| Clearmind Medicine, Inc. | 1.027 |
| Lexaria Bioscience Corp. | 0.8998 |
Price to Book Value Related Metrics
| PS Ratio | 2.584 |
| PEG Ratio | -0.0022 |
| Price | 0.0055 |
| Earnings Yield | -478.2% |
| Market Cap | 0.728M |
| PEGY Ratio | -0.0022 |